The available search results associate the company with molecular diagnostic technologies, including primer, probe, and kit-based detection of EGFR and KRAS genetic mutations
The available search results associate the company with molecular diagnostic technologies, including primer, probe, and kit-based detection of EGFR and KRAS genetic mutations. The patent result names Shenzhen BGI Life Science Research Institute as the assignee, so the connection to 锐讯生物 is not independently confirmed.